CORONA VIRUS INFECTION

This study tested the CoviVac COVID-19 vaccine in 200 adults aged 60 and older. The goal was to see if the vaccine is safe and triggers a strong immune response. Researchers measured side effects and antibody levels after vaccination. The vaccine uses a killed virus to teach the …

This study tested three new self-amplifying RNA vaccines against COVID-19 in 72 healthy adults, including some who had already been vaccinated and some who had not. The main goals were to check safety and measure the immune response. The vaccines were designed to help the body fi…

This early-stage study tested a new drug called SIR1-365 in 45 hospitalized adults with severe COVID-19. The main goal was to see if the drug is safe and tolerable. Researchers also looked at whether it could reduce inflammation and help patients recover. The study was completed,…

This study tested an experimental drug called SAR443122 in 68 hospitalized adults with severe COVID-19. The goal was to see if it could safely reduce dangerous inflammation and improve oxygen levels. Participants received either the drug or a placebo, and researchers measured cha…

This study tested a drug called sarilumab in 420 adults hospitalized with severe COVID-19. The goal was to see if it could speed up recovery and improve survival compared to a placebo. Unfortunately, the drug did not show a clear benefit for these patients.

This study created a global registry to track how COVID-19 impacts kidney function in 500 patients. Researchers aim to understand how often kidney damage occurs and identify who is most at risk. The goal is to gather knowledge that can help improve future care for COVID-19 patien…

This study looked at over 1,000 adults with COVID-19 who were admitted to intensive care units (ICUs) in France. Researchers collected information on how these patients were treated and what complications they had. The goal was to better understand what factors affect their recov…

This study looked at nearly 2000 lung cancer patients to understand how their bodies build immunity after catching COVID-19 or getting vaccinated. Researchers collected medical records and tested blood for antibodies. The goal was to describe patient characteristics and immune re…

This study looked at whether it is safe to give another dose of a COVID-19 mRNA vaccine to people who had a bad reaction to a previous dose, or to people with a history of allergies. It also included people with long COVID. A total of 137 adults took part and received either the …

This study followed 211 older adults who were hospitalized with COVID-19 to see how their ability to move, think, and do daily tasks changed over time. Researchers measured recovery using standard tests of mobility and cognition. The goal is to understand the long-term effects of…

This study looked at how the immune system's T-cells respond to the COVID-19 virus in hospitalized patients. Researchers measured the number of T-cells that produce a key immune signal (interferon-gamma) when exposed to the virus's spike protein. The goal was to better understand…

This study aimed to learn more about how COVID-19 affects children, especially those with cancer. Researchers collected samples from 33 children to study symptoms, risk factors, and how long the virus lasts. The goal was to improve detection and treatment for kids in the future.